Amazon One Medical Introduces Weight Management Program With Upfront GLP-1 Medication Costs

https://www.aboutamazon.com/news/retail/amazon-glp1-management-program

Federal Court Reportedly Halts Kennedy's Vaccine Panel, Putting COVID, Flu And RSV Shots At Risk

FDA court freeze leaves COVID, flu, RSV vaccines in limbo as Kennedy's ACIP overhaul faces legal challenge.

4 Health Care Stocks Whale Activity In Today's Session

Semiconductors Look Dangerously Overheated After Massive Run: Analyst

After a 13-day NASDAQ rally, BTIG's Jonathan Krinsky analyzes market risks and shares where to find better risk-reward opportunities today.

RBC Capital Reiterates Underperform on Pfizer, Maintains $25 Price Target

RBC Capital analyst Trung Huynh reiterates Pfizer (NYSE:PFE) with a Underperform and maintains $25 price target.

Astellas And Pfizer Announce FDA Grants Priority Review To sBLA For Perioperative PADCEV, In Combination With PD-1 Inhibitor Keytruda Or Keytruda QLEX As Treatment For Patients With MIBC; PDU

Submission based on statistically significant event-free and overall survival data from the Phase 3 EV-304 trialBuilding on the existing indication in cisplatin-ineligible muscle-invasive bladder cancer (MIBC), if

Compass Pathways Cheers Trump Order To Accelerate Access To Psychedlic Drug Treatements: 'Recognizes Profound Urgency Of Mental Health Crisis'

Compass Pathways said a White House executive order may speed FDA review of its psilocybin therapy COMP360 for treatment-resistant depression trials.

Trump Accelerates Psychedelic Research With $50 Million Ibogaine Commitment

On Saturday, President Donald Trump signed an executive order directing the U.S. Food and Drug Administration to move faster on reviews tied to psychedelic-based research and treatment, including ibogaine that veteran advocates say may help post-traumatic stress disorder.

4 Health Care Stocks With Whale Alerts In Today's Session

FDA Takes Step Forward on Testosterone Therapy for Men

https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men

Trump Administration Eyes Former Deputy Surgeon General To Lead CDC After Months Of Turmoil: Report

Trump administration reportedly considers Erica Schwartz to lead CDC, pending final approval.

UBS Maintains Neutral on Pfizer, Raises Price Target to $27

UBS analyst Michael Yee maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $25 to $27.

Elon Musk Questions COVID-19 Vaccine Dosage, Says It Was 'Obviously Too High'

Elon Musk raises concerns over COVID-19 vaccine dosage, citing a severe reaction that nearly led to hospitalization.

Trellus Health Extends Pfizer IBD Digital Application Licensing Agreement, Highlighting Resilience-Driven Platform's Value Across Pharmaceutical Lifecycle

Morgan Stanley Maintains Equal-Weight on Pfizer, Raises Price Target to $28

Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $27 to $28.

Study Showing 50% Drop In COVID ER Visits Thanks To The Vaccine Put On Hold By CDC: Report

The CDC has reportedly delayed a report showing COVID-19 vaccine benefits, citing methodology concerns.

4 Health Care Stocks Whale Activity In Today's Session

B of A Securities Maintains Neutral on Pfizer, Lowers Price Target to $26

B of A Securities analyst Jason Gerberry maintains Pfizer (NYSE:PFE) with a Neutral and lowers the price target from $27 to $26.

Novavax Faces Shareholder Revolt As Shah Capital Criticizes Strategy

Shah Capital plans to oppose Novavax board and pay, citing weak returns, high costs, and strategic missteps despite the vaccine pipeline.

Why Is Pfizer Stock Dropping Tuesday?

Pfizer Inc (NYSE:PFE) shares are trading lower on Tuesday after the company and its COVID-19 vaccine partner paused an updated-shot trial.

Corbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive Edge

Corbus reports FDA alignment on the CRB-701 path, as analysts flag upside tied to the head and neck cancer opportunity and obesity pipeline.

CDC Halts Testing For 27 Infectious Diseases Including COVID-19, Rabies Amid Agency Downsizing

CDC pauses 27 infectious disease tests, including COVID-19, rabies, amid downsizing under HHS, while some tests remain commercially available.

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

According to a Bloomberg report, Trump may impose 100% tariffs on drugmakers without pricing deals, as part of a broader push to lower drug costs.

Pfizer, BioNTech Hit Pause On COVID Shot Trial As Enrollment Falls Flat

Pfizer & BioNTech halt recruitment for a major U.S. COVID vaccine trial for adults 50–64 due to low enrollment. Read the latest updates.

'Pfizer Wins €1.9 Billion Covid Vaccine Case With Poland, Romania' - Bloomberg

https://www.bloomberg.com/news/articles/2026-04-01/pfizer-wins-1-9-billion-covid-vaccine-case-with-poland-romania

'Pfizer And Partner BioNTech Say They Will Stop U.S. Covid-19 Vaccine Study In Healthy Adults Ages 50 To 64 Due To Slow Enrollment' - Reuters Exclusive

Vaccine makers Pfizer PFE.N and BioNTech 22UAy.DE have halted recruitment for a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to generate the needed data.

GSK's Partner Shionogi Acquires Pfizer's Stake In ViiV Healthcare For $2.125B

https://www.shionogi.com/global/en/news/2026/04/20260401_12.html